Search research articles
Contact Us
Filters
Showing results (711-720 of 932) with videos related to
Page
of 94
Sort By:
Journal of the American College of Cardiology
|
July 18, 2015
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium
Gregg W Stone, David H Adams, William T Abraham, et al.
The New England Journal of Medicine
|
July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
W S Colucci, U Elkayam, D P Horton, et al.
Circulation
|
October 1, 2019
Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial
Suzanne J Baron, Kaijun Wang, Suzanne V Arnold, et al.
Journal of the American College of Cardiology
|
November 15, 2008
Changing preferences for survival after hospitalization with advanced heart failure
Lynne W Stevenson, Anne S Hellkamp, Carl V Leier, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
European Journal of Heart Failure
|
April 27, 2025
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
Antoni Bayes-Genis, Matteo Pagnesi, Pau Codina, et al.
European Heart Journal
|
July 15, 2015
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium
Gregg W Stone, David H Adams, William T Abraham, et al.
European Heart Journal
|
May 27, 2015
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
Jan Steffel, Michele Robertson, Jagmeet P Singh, et al.
Journal of the American College of Cardiology
|
September 6, 2005
Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study
Cathrine Wold Knudsen, Torbjørn Omland, Paul Clopton, et al.
European Heart Journal
|
April 21, 2017
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial
Jeroen J Bax, Victoria Delgado, Peter Sogaard, et al.
Page
of 94
Search research articles
Search
Showing results (711-720 of 932) with videos related to
Sort By:
Page
of 94
Journal of the American College of Cardiology
|
July 18, 2015
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium
Gregg W Stone, David H Adams, William T Abraham, et al.
The New England Journal of Medicine
|
July 27, 2000
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
W S Colucci, U Elkayam, D P Horton, et al.
Circulation
|
October 1, 2019
Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial
Suzanne J Baron, Kaijun Wang, Suzanne V Arnold, et al.
Journal of the American College of Cardiology
|
November 15, 2008
Changing preferences for survival after hospitalization with advanced heart failure
Lynne W Stevenson, Anne S Hellkamp, Carl V Leier, et al.
Journal of Cardiac Failure
|
May 22, 2026
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design
Farooq H Sheikh, William T Abraham, Philip B Adamson, et al.
European Journal of Heart Failure
|
April 27, 2025
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC
Antoni Bayes-Genis, Matteo Pagnesi, Pau Codina, et al.
European Heart Journal
|
July 15, 2015
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium
Gregg W Stone, David H Adams, William T Abraham, et al.
European Heart Journal
|
May 27, 2015
The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial
Jan Steffel, Michele Robertson, Jagmeet P Singh, et al.
Journal of the American College of Cardiology
|
September 6, 2005
Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study
Cathrine Wold Knudsen, Torbjørn Omland, Paul Clopton, et al.
European Heart Journal
|
April 21, 2017
Prognostic implications of left ventricular global longitudinal strain in heart failure patients with narrow QRS complex treated with cardiac resynchronization therapy: a subanalysis of the randomized EchoCRT trial
Jeroen J Bax, Victoria Delgado, Peter Sogaard, et al.
Page
of 94